Project measures / variables set:   Harrill2   ALT

ID, description, units MPD:44111   ALT   alanine transaminase (serum ALT)   [IU/L]  
DB289 study
Measures
• control    • DB289    • difference
Data set, strains Harrill2   inbred   34 strains     sex: f     age: 6-8wks
Procedure metabolic panel
Comparisoncontrol group vs. treated group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Harrill2 - alanine transaminase (serum ALT)




  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 420905.9212 420905.9212 574.9441 < 0.0001
strain 33 229885.9189 6966.24 9.5157 < 0.0001
group:strain 33 160643.5906 4867.9876 6.6495 < 0.0001
Residuals 268 196197.8235 732.0814

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Harrill2 44111 metabolic panel DB289 alanine transaminase (serum ALT)   [IU/L]   control  ALT_ctrl inbred 34 f 6-8wks
Harrill2 44112 metabolic panel DB289 alanine transaminase (serum ALT)   [IU/L]   DB289  ALT_trt inbred 34 f 6-8wks
Harrill2 44211 metabolic panel DB289 alanine transaminase (serum ALT)   [IU/L]   difference  ALT_fold inbred 34 f 6-8wks (supplemental /
  summary measure)